Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice

(2021) Giulia Bonaldo et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Chimeric antigen receptor T ‐cells safety: A pharmacovigilance and meta‐analysis study

(2021) Charles Dolladille et al.   AMERICAN JOURNAL OF HEMATOLOGY

Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline

(2021) Bianca D. Santomasso et al.   JOURNAL OF CLINICAL ONCOLOGY

Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System

(2021) Michele Fusaroli et al.   Frontiers in Pharmacology

CAR T-cell product performance in haematological malignancies before and after marketing authorisation

(2020) Magdi Elsallab et al.   LANCET ONCOLOGY

Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance

(2020) Emanuel Raschi et al.   Targeted Oncology

Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 years

(2020) Marjorie E. Zettler et al.   Journal of Geriatric Oncology

Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis

(2020) Avirup Guha et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Neurological adverse events following CAR T-cell therapy: a real-world analysis

(2020) Ajeet Gajra et al.   Immunotherapy

Tisagenlecleucel in Children and Young Adults: Reverse Translational Research by Using Real-World Safety Data

(2020) Concetta Rafaniello et al.   Pharmaceuticals

Cytokine Storm

(2020) David C. Fajgenbaum et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)

(2019) Raza M. Alvi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy

(2018) Kevin A. Hay   BRITISH JOURNAL OF HAEMATOLOGY

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

(2018) Frederick L Locke et al.   LANCET ONCOLOGY

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

(2018) Stephen J. Schuster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

(2017) Sattva S. Neelapu et al.   Nature Reviews Clinical Oncology

Toxicities of chimeric antigen receptor T cells: recognition and management

(2016) Jennifer N. Brudno et al.   BLOOD

A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma

(2016) Knut B. Smeland et al.   BRITISH JOURNAL OF HAEMATOLOGY

The IMI PROTECT project: purpose, organizational structure, and procedures

(2016) Robert F. Reynolds et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

(2015) Daniel W Lee et al.   LANCET

Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia

(2015) Hanren Dai et al.   OncoImmunology

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

(2014) Shannon L. Maude et al.   NEW ENGLAND JOURNAL OF MEDICINE

A new method for constructing networks from binary data

(2014) Claudia D. van Borkulo et al.   Scientific Reports

Data Mining of the Public Version of the FDA Adverse Event Reporting System

(2013) Toshiyuki Sakaeda et al.   International Journal of Medical Sciences

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

(2013) Stephan A. Grupp et al.   NEW ENGLAND JOURNAL OF MEDICINE

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

(2011) J. N. Kochenderfer et al.   BLOOD

Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery

(2011) G Niklas Norén et al.   STATISTICAL METHODS IN MEDICAL RESEARCH